Full-Time

Facilities Manager

Posted on 11/18/2024

Veracyte

Veracyte

501-1,000 employees

Develops genomic tests for cancer diagnosis

Biotechnology
Healthcare

Compensation Overview

$109k - $136.5kAnnually

+ Bonus + Incentives + Restricted Stock Units

Senior

San Bruno, CA, USA

On-site role at South San Francisco laboratories.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Requirements
  • Bachelor’s degree in Facilities Management, Engineering, or related field (or equivalent experience).
  • 8+ years of facilities management experience, preferably in biotech/pharma.
  • Experience managing high-volume, regulated lab facilities.
  • Strong OSHA knowledge and safety program implementation.
  • Proficiency in HVAC/plumbing systems and lab space planning.
  • Vendor management and cost control expertise.
  • Multi-site management and effective prioritization skills.
  • Excellent communication, leadership, problem-solving, and decision-making abilities.
Responsibilities
  • Oversee daily operations and maintenance of warehouse, lab, and office spaces, ensuring safety and functionality of all areas.
  • Work with laboratory and quality teams to meet CLIA, CAP, and NYDOH standards, including scheduling preventive maintenance and ensuring regulatory compliance.
  • Stay current with OSHA regulations and training, enforcing safety protocols and maintaining IIPP documentation and incident reports.
  • Support EHS programs to promote a safe work environment and minimize risks.
  • Coordinate with contractors to maintain HVAC and plumbing systems, ensuring lab conditions meet industry standards.
  • Manage vendor relationships, obtain competitive bids, negotiate contracts, and oversee work quality.
  • Track expenses and identify cost-saving opportunities and ensure projects stay within budget.
  • Create and implement emergency response plans and conduct training and drills.
  • Collaborate with Director of Facilities, team leaders, architects and engineers on lab design, optimizing for safety and compliance.

Veracyte specializes in cancer diagnostics by developing advanced genomic tests that assist in the early detection and diagnosis of various cancers. Their tests analyze genetic information from non-invasive samples, such as nasal swabs or tissue biopsies, providing crucial insights into the presence and progression of cancer. This allows healthcare providers, including hospitals and clinics, to make informed treatment decisions tailored to individual patients. Veracyte differentiates itself from competitors by focusing on non-invasive testing methods and continuously investing in research to expand its product offerings. The company's goal is to improve patient outcomes and enhance the efficiency of cancer treatment through accurate and early diagnosis.

Company Stage

IPO

Total Funding

$69.4M

Headquarters

San Francisco, California

Founded

N/A

Growth & Insights
Headcount

6 month growth

5%

1 year growth

7%

2 year growth

10%
Simplify Jobs

Simplify's Take

What believers are saying

  • Recognition as a Bay Area Top Workplace for 11 consecutive years highlights a positive work environment and strong company culture.
  • Significant investments from firms like Aigen Investment Management and Quest Partners indicate strong financial backing and growth potential.
  • The upcoming launch of ClearLab and an MRD assay in 2026 showcases Veracyte's commitment to expanding its product portfolio and market reach.

What critics are saying

  • The competitive landscape in genomic diagnostics is intense, requiring Veracyte to continuously innovate to maintain its market position.
  • Dependence on successful clinical validation and regulatory approval for new tests can pose risks to product launch timelines.

What makes Veracyte unique

  • Veracyte specializes in non-invasive genomic tests for early cancer detection, setting it apart from traditional diagnostic methods.
  • Their Decipher Prostate and Bladder Genomic Classifiers offer superior prognostic information compared to standard approaches, enhancing treatment personalization.
  • Continuous investment in R&D and clinical validation ensures that Veracyte's tests remain at the forefront of cancer diagnostics.

Help us improve and share your feedback! Did you find this helpful?